Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / STSA - Satsuma Pharmaceuticals GAAP EPS of -$0.48

STSA - Satsuma Pharmaceuticals GAAP EPS of -$0.48

Satsuma Pharmaceuticals Inc.
  • Satsuma Pharmaceuticals press release ( NASDAQ: STSA ): Q3 GAAP EPS of -$0.48.
  • As of September 30, 2022, Satsuma had $64.4 million in combined cash, cash equivalents and marketable securities, which it believes is sufficient to fund operations into the second half of 2023 and through projected completion of STS101 Phase 3 clinical development and potential submission of an NDA for STS101 in Q1 2023.

For further details see:

Satsuma Pharmaceuticals GAAP EPS of -$0.48
Stock Information
Company Name: Satsuma Pharmaceuticals Inc.
Stock Symbol: STSA
Market: NYSE
Menu
STSA STSA Quote STSA Short STSA News STSA Articles STSA Message Board
Get STSA Alerts

News, Short Squeeze, Breakout and More Instantly...